P. Lissoni
Impact in
-
- Circadian rhythm and melatonin
-
- Tryptophan and brain disorders
Papers in
- Oncology 13
- Cancer Immunotherapy and Biomarkers 8
- Cancer Treatment and Pharmacology 3
-
- Circadian rhythm and melatonin 12
- Co-authors
- Gabriele Tancini (22 shared papers)Sandro Barni (16 shared papers)Franco Rovelli (6 shared papers)Fabio Malugani (5 shared papers)S. Barni (6 shared papers)Luca Fumagalli (5 shared papers)F Brivio (5 shared papers)G Gardani (4 shared papers)
- Journals
- The International Journal of Biological Markers (7 papers)Oncology (2 papers)Cancer (2 papers)Frontiers of hormone research (1 paper)Journal of Pineal Research (1 paper)
- Partner nations
- ItalySwitzerlandUnited States
In The Last Decade
P. Lissoni
35 papers receiving 454 citations
Peers
Comparison fields: 5 of 73
- Endocrine and Autonomic Systems 119
- Biological Psychiatry 27
- Immunology 114
- Oncology 122
- Behavioral Neuroscience 15
Countries citing papers authored by P. Lissoni
This map shows the geographic impact of P. Lissoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Lissoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Lissoni more than expected).
Fields of papers citing papers by P. Lissoni
This network shows the impact of papers produced by P. Lissoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Lissoni. The network helps show where P. Lissoni may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Lissoni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 67 | |
| 2 | Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic disease. | 2000 | 39 |
| 3 | 1992 | 38 | |
| 4 | 2003 | 30 | |
| 5 | Endocrine effects of a 24-hour intravenous infusion of interleukin-2 in the immunotherapy of cancer. | 1990 | 27 |
| 6 | 1990 | 26 | |
| 7 | 2003 | 23 | |
| 8 | A phase II study of chemoneuroimmunotherapy with platinum, subcutaneous low-dose interleukin-2 and the pineal neurohormone melatonin (P.I.M.) as a second-line therapy in metastatic melanoma patients progressing on dacarbazine plus interferon-alpha. | 2003 | 23 |
| 9 | Ultradian chronomodulation by melatonin of a Placebo effect upon human killer cell activity. | 1987 | 20 |
| 10 | Ten-year survival results in metastatic renal cell cancer patients treated with monoimmunotherapy with subcutaneous low-dose interleukin-2. | 2002 | 19 |
| 11 | 2001 | 17 | |
| 12 | Relation between macrophage and T helper-2 lymphocyte functions in human neoplasms: neopterin, interleukin-10 and interleukin-6 blood levels in early or advanced solid tumors. | 1996 | 16 |
| 13 | Enhanced secretion of tumour necrosis factor in patients with myocardial infarction. | 1992 | 15 |
| 14 | 1997 | 14 | |
| 15 | Effects of a preoperative course of interleukin-2 on surgical and immunobiological variables in patients with colorectal cancer: a phase 2 study. | 1993 | 14 |
| 16 | Treatment of cancer-related thrombocytopenia by low-dose subcutaneous interleukin-2 plus the pineal hormone melatonin: a biological phase II study. | 1997 | 14 |
| 17 | 2000 | 12 | |
| 18 | Amplification of eosinophilia by melatonin during the immunotherapy of cancer with interleukin-2. | 1993 | 12 |
| 19 | 1999 | 9 | |
| 20 | 2009 | 9 |
About P. Lissoni
P. Lissoni is a scholar working on Oncology, Endocrine and Autonomic Systems, Immunology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 495 indexed citations. Recurring topics across this work include Circadian rhythm and melatonin (12 papers), Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (4 papers), Cancer Treatment and Pharmacology (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers), Cancer, Stress, Anesthesia, and Immune Response (3 papers) and Cancer-related cognitive impairment studies (2 papers). The work is most often cited by research in Endocrine and Autonomic Systems (119 citations), Biological Psychiatry (27 citations), Immunology (114 citations), Oncology (122 citations) and Behavioral Neuroscience (15 citations). P. Lissoni has collaborated with scholars based in Italy, Switzerland and United States. Frequent co-authors include Gabriele Tancini, Sandro Barni, Franco Rovelli, Fabio Malugani, S. Barni, Luca Fumagalli, F Brivio, G Gardani, Ario Conti and E. Tisi. Their work appears in journals such as The International Journal of Biological Markers, Oncology, Cancer, Frontiers of hormone research and Journal of Pineal Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.